Clinical and epidemiological profile of patients with hypertensive peak after Ahmed glaucoma valve implant
Abstract Objective: To report the clinical epidemiological profile of patients who presented the hypertensive peak after VAT and to indicate possible associated risk factors. Methods: A retrospective, observational and descriptive study (review of medical records of patients assisted in the IBOPC) from 2014 to 2016. Results: We analyzed 40 patients with glaucoma submitted to Ahmed Glaucoma Valve implant. The most common preoperative diagnosis was secondary glaucoma, with the most frequent corneal penetrating post-transplant indication. 95% of the surgeries were of isolated tube implantation. 56% of patients had previous anti-glaucomatous surgery. 46% needed a posterior surgical procedure to manage postoperative complications, and the most frequent was atalamia (9.7%). IOP preoperatively = 28.6 ± 12.20mmHg, with use of 3.41 medications. At 3 weeks the mean IOP increased to 16mmHg, with use of 0.42 medications. After 3 months of surgery the mean IOP was 16.5mmHg, with use of 1.86 of medications. After 6 months of follow-up the mean IOP decreased (16.4 ± 6.74 mmHg), with 2.23 ± 1.45 medications. The mean of the AV (Snellen) was 20 / 100p in the preoperative period and 20/200 after the 6th month of surgery. Fourteen patients fulfilled the criteria for HP, of which 6 obtained HP resolution. Of the patients who developed HP, 78.4% started to elevate IOP between the 2nd and 4th postoperative week. Six (14.6%) patients had complete surgical success, partial in 36.6% and bankruptcy in 31%. Conclusion: The hypertensive phase may occur in part of the patients after the initial weeks of the surgical procedure. The knowledge of this phenomenon, the previous preparation of the surgeon, the regular monitoring of the patient and the control of IOP with the use of medications are determinant in the resolution of this complication.